P. Paktipat, Ampornpun Theeranut, Sirirat Anutrakulchai, S. Lertsinudom
{"title":"Achieving smoking cessation through collaborative efforts between community pharmacists and health volunteers","authors":"P. Paktipat, Ampornpun Theeranut, Sirirat Anutrakulchai, S. Lertsinudom","doi":"10.29090/psa.2023.03.23.243","DOIUrl":null,"url":null,"abstract":"The objective of this study was to develop, implement, and evaluate a collaborative smoking cessation program (CSCP) involving community pharmacists and village health volunteers (VHVs) in a rural community. Our strategy included establishment, implementation, and reflection. The CSCP was established through group discussions among community pharmacists, VHVs, and a local officer. VHVs identified smokers and provided basic counselling, while community pharmacists provided smokers specific and intensive counselling. We also assessed clinical outcomes, such as peak expiratory flow rate (PEFR), exhaled partial carbon monoxide (PCO), and continuous abstinence rate (CAR). Finally, interviews from the reflection phase were conducted to investigate attitudes towards participating in the CSCP and unsuccessful quitting. CSCP was completed by 101 out of 108 initial participants. All were men, with an average age of 55.2±10.75 years. After six months, the CSCP resulted in a significant decrease in the mean PCO ( P =0.010). Moreover, 23 smokers successfully quit smoking, yielding a six-month CAR of 22.8% and stated that the CSCP enforced their perseverance. However, 78 volunteers (72.2%) could not quit smoking owing to withdrawal symptoms and influence from their immediate environment. CSCP is a novel smoking cessation model, which should be promoted to enforce smoking cessation in the community. However, significant efforts and coordination of relevant stakeholders are required.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"180 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Sciences Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29090/psa.2023.03.23.243","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
The objective of this study was to develop, implement, and evaluate a collaborative smoking cessation program (CSCP) involving community pharmacists and village health volunteers (VHVs) in a rural community. Our strategy included establishment, implementation, and reflection. The CSCP was established through group discussions among community pharmacists, VHVs, and a local officer. VHVs identified smokers and provided basic counselling, while community pharmacists provided smokers specific and intensive counselling. We also assessed clinical outcomes, such as peak expiratory flow rate (PEFR), exhaled partial carbon monoxide (PCO), and continuous abstinence rate (CAR). Finally, interviews from the reflection phase were conducted to investigate attitudes towards participating in the CSCP and unsuccessful quitting. CSCP was completed by 101 out of 108 initial participants. All were men, with an average age of 55.2±10.75 years. After six months, the CSCP resulted in a significant decrease in the mean PCO ( P =0.010). Moreover, 23 smokers successfully quit smoking, yielding a six-month CAR of 22.8% and stated that the CSCP enforced their perseverance. However, 78 volunteers (72.2%) could not quit smoking owing to withdrawal symptoms and influence from their immediate environment. CSCP is a novel smoking cessation model, which should be promoted to enforce smoking cessation in the community. However, significant efforts and coordination of relevant stakeholders are required.
Pharmaceutical Sciences AsiaPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
0.90
自引率
0.00%
发文量
59
期刊介绍:
The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: Clinical Pharmacy Drug Synthesis and Discovery Targeted-Drug Delivery Pharmaceutics Biopharmaceutical Sciences Phytopharmaceutical Sciences Pharmacology and Toxicology Pharmaceutical Chemistry Nutraceuticals and Functional Foods Natural Products Social, Economic, and Administrative Pharmacy Clinical Drug Evaluation and Drug Policy Making Antimicrobials, Resistance and Infection Control Pharmacokinetics and Pharmacodynamics.